Entero Therapeutics, Inc.

ENTO · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$163$3,712$1,363$8,249
Short-Term Investments$0$0$0$0
Receivables$0$0$93$0
Inventory$0$0$0$0
Other Curr. Assets$83,315$1,244$1,957$1,176
Total Curr. Assets$83,479$4,956$3,413$9,425
Property Plant & Equip (Net)$127$210$303$409
Goodwill$1,684$1,684$1,684$1,912
Intangibles$0$0$0$0
Long-Term Investments$22$22$22$0
Tax Assets$0$0$0$0
Other NC Assets$98$11$18$44
Total NC Assets$1,931$1,927$2,027$2,365
Other Assets$0$0$0$0
Total Assets$85,410$6,883$5,440$11,790
Liabilities
Payables$2,959$554$720$2,682
Short-Term Debt$82$680$670$719
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$24,505$1,899$1,094$8,899
Total Curr. Liab.$27,546$3,133$2,483$12,300
LT Debt$59$147$214$311
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$7,000
Total NC Liab.$59$147$214$7,311
Other Liabilities$0$0$0$0
Cap. Leases$59$147$214$311
Total Liabilities$27,605$3,280$2,698$19,612
Equity
Pref Stock$61,681$0$0$0
Common Stock$0$0$0$1
Retained Earnings-$202,388-$184,329-$168,534-$153,904
AOCI$0$0$0-$1,224
Other Equity$198,511$187,931$171,276$147,305
Total Equity$57,804$3,603$2,742-$7,822
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$85,410$6,883$5,440$11,790
Net Debt-$23-$2,885-$479-$7,218